Evidence map›Paper›PMID 28167531›Full record

ArticleThe Journal of biological chemistry2017

Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.

Eimile Oakes, Ashley Anderson, Aaron Cohen-Gadol, Heather A Hundley

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 188 citations in OpenAlex.

  1. Review
  2. Two codes of RNA editing by deamination in human diseases.Experimental & molecular medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. mRNA Transcript Variants Expressed in Mammalian Cells.International journal of molecular sciences · 2025
    Review
  19. Review
  20. ncRNA Editing: Functional Characterization and Computational Resources.Methods in molecular biology (Clifton, N.J.) · 2025
    Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eimile OakesFrom the Department of Biology and.
Ashley AndersonMedical Sciences Program, Indiana University, Bloomington, Indiana 47405 and.
Aaron Cohen-GadolDepartment of Neurological Surgery, Goodman Campbell Brain and Spine, Indianapolis, Indiana 46202.
Heather A HundleyMedical Sciences Program, Indiana University, Bloomington, Indiana 47405 and hahundle@indiana.edu.
Indiana University Bloomington · USNeurological Surgery · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA editing is a cellular process that precisely alters nucleotide sequences, thus regulating gene expression and generating protein diversity. Over 60% of human transcripts undergo adenosine to inosine RNA editing, and editing is required for normal development and proper neuronal function of animals. Editing of one adenosine in the transcript encoding the glutamate receptor subunit B, glutamate receptor ionotropic AMPA 2 (GRIA2), modifies a codon, replacing the genomically encoded glutamine (Q) with arginine (R); thus this editing site is referred to as the Q/R site. Editing at the Q/R site of

Indexed as

Adenosine DeaminaseAdultAgedAstrocytesBrainCase-Control StudiesCells, CulturedFemaleGlioblastomaGlutamic AcidHumansMaleMiddle AgedNeoplasm GradingReceptors, AMPARNA-Binding ProteinsADA protein, humanADARB1 protein, humanAdenosine Deaminaseglutamate receptor ionotropic, AMPA 2Glutamic AcidReceptors, AMPARNA-Binding ProteinsRNA, MessengerRNA PrecursorsADARADAR3adenosine deaminasecancerdouble-stranded RNA (dsRNA)glioblastomaglutamate receptorGRIA2inosineRNA editing

Identifiers

PMID28167531
PMCPMC5354488
OpenAlexW2586244292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.